How are we changing clinical trials?

How are we changing clinical trials?

How are we changing clinical trials?

Blog

CTAD 2020: Unlearn will present abstracts to demonstrate how Digital Twins enable smaller, more efficient trials

Unlearn will present data from two separate abstracts demonstrating how Digital Twins can power novel trial designs and accelerate timelines.
Publications

Digital Control Subjects for Alzheimer's Disease Clinical Trials (AMIA 2019)

Blog

Reflections on AAIC 2019: Community, Cause, and Challenges

Blog

Learning from Data Across the Alzheimer's Disease Spectrum

At AAIC, I watched the talks with this question in mind: how would we build a model of disease progression in the early stages of AD?
While treating the patient is the utmost priority, we need to understand that Alzheimer’s impacts every part of a person’s life and to address all of those parts, both effectively and compassionately.
The ability to simulate dozens of clinical characteristics simultaneously is a powerful tool to model disease progression.

Machine learning for comprehensive forecasting of Alzheimer's Disease progression

Blog

Digital Twins: A Tool for Risk Mitigation in the Era of COVID-19

In what ways can we mitigate risk and apply innovative solutions to unstable trials in the wake of COVID-19?
No items found.
No items found.
No items found.
No items found.
No items found.

Contact us

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.